259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up Salomone Di SaverioFausto CatenaMario Taffurelli Review 09 August 2007 Pages: 405 - 416
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings Wei T. YangHuong T. Le-PetrossMassimo Cristofanilli Review 26 July 2007 Pages: 417 - 426
Precancerous model of human breast epithelial cells induced by NNK for prevention Nalin SiriwardhanaShambhunath ChoudharyHwa-Chain Robert Wang Preclinical Study 26 July 2007 Pages: 427 - 441
Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity Hiromi SakaguchiAyumi KodamaShun Higuchi Preclinical Study 28 July 2007 Pages: 443 - 450
Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death Elena P. MoiseevaRaimond Heukers Preclinical Study 26 July 2007 Pages: 451 - 462
Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer Ander UrruticoecheaHelena AguilarJosep Ramon Germà-Lluch Preclinical Study 19 July 2007 Pages: 463 - 470
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75 Teresa PuigAlejandro Vázquez-MartínRamon Colomer Preclinical Study 28 September 2007 Pages: 471 - 479
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer Keun Seok LeeJungsil RoSeok-Ki Kim Clinical Trial 26 July 2007 Pages: 481 - 489
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen Mario CamponeLoïc CampionPascal Jézéquel Clinical Trial 21 July 2007 Pages: 491 - 501
Sentinel node biopsy in patients with multiple breast cancer Hee Jeong KimJung Sun LeeSei Hyun Ahn Clinical Trial 28 July 2007 Pages: 503 - 506
BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy Kathryn J. Schlich-BakkerMargreet G. E. M. AusemsJan van den Bout Clinical Trial Open access 03 August 2007 Pages: 507 - 514
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women David CellaStephanie R. LandPatricia A. Ganz Clinical Trial 13 September 2007 Pages: 515 - 526
SSRI use and breast cancer risk by hormone receptor status Patricia F. CooganBrian L. StromLynn Rosenberg Epidemiology 19 July 2007 Pages: 527 - 531
NSAID use and breast cancer risk in the VITAL cohort Ann ReadyChristine M. VelicerEmily White Epidemiology 03 August 2007 Pages: 533 - 543
Parity and disparity in first course treatment of invasive breast cancer Mary Jo LundOtis P. BrawleyJ. William Eley Epidemiology 21 July 2007 Pages: 545 - 557
The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data Takeru ShiroiwaTakashi FukudaKiichiro Tsutani Epidemiology 28 July 2007 Pages: 559 - 566
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer R. A. NoutW. E. FietsJ. W. R. Nortier Epidemiology Open access 28 July 2007 Pages: 567 - 572
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors Marilyn L. KwanLaurel A. HabelBette Caan Epidemiology 03 August 2007 Pages: 573 - 579
Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques Michal KonecnyKatarina ZavodnaZdena Bartosova Letter to the Editor 28 July 2007 Pages: 581 - 583
30th Annual San Antonio Breast Cancer Symposium Late Breaking Abstracts Abstract 17 April 2008 Pages: 585 - 594
